Financials The Joint Corp.

Equities

JYNT

US47973J1025

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
12.23 USD +1.24% Intraday chart for The Joint Corp. +0.41% +27.26%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 223.8 368.7 946.8 203.1 141.8 180.7 -
Enterprise Value (EV) 1 215.4 353.1 929.4 195.4 141.8 180.7 180.7
P/E ratio 70.2 x 29.2 x 137 x 175 x -14.6 x 278 x 31.4 x
Yield - - - - - - -
Capitalization / Revenue 4.62 x 6.28 x 11.7 x 1.99 x 1.2 x 1.63 x 1.84 x
EV / Revenue 4.62 x 6.28 x 11.7 x 1.99 x 1.2 x 1.63 x 1.84 x
EV / EBITDA 36.1 x 40.5 x 71.4 x 17.6 x 11.6 x 17.5 x 11 x
EV / FCF 55.1 x 45.9 x 115 x 39.2 x 14.6 x 30.2 x 14.8 x
FCF Yield 1.81% 2.18% 0.87% 2.55% 6.83% 3.31% 6.76%
Price to Book 40.8 x 17.9 x 32.1 x 6.26 x 5.73 x 7.84 x 6.87 x
Nbr of stocks (in thousands) 13,863 14,041 14,413 14,530 14,754 14,776 -
Reference price 2 16.14 26.26 65.69 13.98 9.610 12.23 12.23
Announcement Date 3/5/20 3/4/21 2/24/22 3/9/23 3/7/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 48.45 58.68 81.19 101.9 117.7 110.9 98.01
EBITDA 1 6.196 9.103 13.25 11.52 12.21 10.32 16.37
EBIT 1 3.415 5.492 6.009 2.077 -2.073 1.264 7.528
Operating Margin 7.05% 9.36% 7.4% 2.04% -1.76% 1.14% 7.68%
Earnings before Tax (EBT) 1 3.372 5.413 5.939 1.944 1.639 1.204 7.528
Net income 1 3.324 13.17 7.159 1.177 -9.752 0.6146 6.054
Net margin 6.86% 22.44% 8.82% 1.16% -8.29% 0.55% 6.18%
EPS 2 0.2300 0.9000 0.4800 0.0800 -0.6600 0.0440 0.3900
Free Cash Flow 1 4.058 8.027 8.243 5.186 9.679 5.975 12.22
FCF margin 8.37% 13.68% 10.15% 5.09% 8.22% 5.39% 12.47%
FCF Conversion (EBITDA) 65.49% 88.18% 62.19% 45.03% 79.29% 57.92% 74.64%
FCF Conversion (Net income) 122.08% 60.96% 115.14% 440.48% - 972.23% 201.87%
Dividend per Share - - - - - - -
Announcement Date 3/5/20 3/4/21 2/24/22 3/9/23 3/7/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 20.99 22.43 22.44 25.06 26.6 27.81 28.45 29.31 29.47 30.61 29.59 28.94 26.82 26.01 23.5
EBITDA 1 3.297 2.741 1.783 2.635 3.129 3.968 2.035 3.232 2.897 4.041 2.251 2.448 2.605 3.013 3.95
EBIT 1 1.339 0.6632 -0.1764 0.4732 0.5005 1.28 -0.6782 -0.3746 -0.898 -0.1474 -0.0526 0.1734 0.3328 0.79 1.65
Operating Margin 6.38% 2.96% -0.79% 1.89% 1.88% 4.6% -2.38% -1.28% -3.05% -0.48% -0.18% 0.6% 1.24% 3.04% 7.02%
Earnings before Tax (EBT) 1 1.323 0.6474 -0.1926 0.4539 0.4752 1.207 3.143 -0.4811 -0.9043 -0.1439 -0.0676 0.1584 0.3178 0.775 1.65
Net income 1 1.937 0.2236 -0.2058 0.3447 0.4911 0.5472 2.301 -0.1904 -0.7163 -11.04 -0.063 0.0672 0.1556 0.4944 1.3
Net margin 9.23% 1% -0.92% 1.38% 1.85% 1.97% 8.09% -0.65% -2.43% -36.07% -0.21% 0.23% 0.58% 1.9% 5.53%
EPS 2 0.1300 0.0100 -0.0100 0.0200 0.0300 0.0400 0.1500 -0.0100 -0.0500 -0.7500 -0.006000 0.004000 0.0100 0.0320 0.0850
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/5/22 8/4/22 11/3/22 3/9/23 5/4/23 9/13/23 11/9/23 3/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position 8.4 15.6 17.4 7.75 - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 4.06 8.03 8.24 5.19 9.68 5.98 12.2
ROE (net income / shareholders' equity) 103% 99.5% 28.6% 3.8% - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 0.4000 1.470 2.050 2.230 1.680 1.560 1.780
Cash Flow per Share - - - - - - -
Capex 1 3.48 3.16 6.99 5.9 5 3.9 1.8
Capex / Sales 7.19% 5.38% 8.61% 5.79% 4.25% 3.52% 1.84%
Announcement Date 3/5/20 3/4/21 2/24/22 3/9/23 3/7/24 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
12.23 USD
Average target price
12.19 USD
Spread / Average Target
-0.35%
Consensus
  1. Stock Market
  2. Equities
  3. JYNT Stock
  4. Financials The Joint Corp.